 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- || RegStem (autologous mesenchymal stromal cell therapy) / EMO Biomedicine Corp
Trial completion, Stroma: Treatment of Knee Osteoarthritis With Autologous Mesenchymal Stromal Cell Product (RegStem) (clinicaltrials.gov) - Nov 14, 2019
P1, N=12, Completed, Sponsor: EMO Biomedicine Corporation
Recruiting --> Completed
- | RegStem (autologous mesenchymal stromal cell therapy) / EMO Biomedicine Corp
Enrollment open, Stroma: Treatment of Knee Osteoarthritis With Autologous Mesenchymal Stromal Cell Product (RegStem) (clinicaltrials.gov) - Aug 4, 2017
P1, N=14, Recruiting, Sponsor: EMO Biomedicine Corporation
Recruiting --> Completed Not yet recruiting --> Recruiting
- | RegStem (autologous mesenchymal stromal cell therapy) / EMO Biomedicine Corp
Phase classification, Trial initiation date, Stroma: Treatment of Knee Osteoarthritis With Autologous Mesenchymal Stromal Cell Product (RegStem) (clinicaltrials.gov) - May 16, 2017
P1, N=14, Not yet recruiting, Sponsor: EMO Biomedicine Corporation
Not yet recruiting --> Recruiting Phase classification: P1/2 --> P1 | Initiation date: Mar 2017 --> Jul 2017
- RegStem (autologous mesenchymal stromal cell therapy) / EMO Biomedicine Corp
New P1/2 trial, Stroma: Treatment of Knee Osteoarthritis With Autologous Mesenchymal Stromal Cell Product (RegStem) (clinicaltrials.gov) - Jan 4, 2017
P1/2, N=14, Not yet recruiting, Sponsor: EMO Biomedicine Corporation